ABMD

Abiomed Inc.

Price

return (12m)

0.00%

p/e

64.27

p/bv

11.14

DIVIDEND YIELD

0.00%

ABMD price

Abiomed

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ABMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ABMD

Valuation

P/E

64.27

Sector -2.36

Industry 0.98

P/BV

11.14

Sector 2.16

Industry 2.53

P/Revenue (PSR)

15.96

Sector 2.00

Industry 0.76

P/EBITDA

60.87

Sector -0.13

Industry 1.08

P/EBIT

67.48

Sector -2.10

Industry 3.17

P/Total Assets

10.11

Sector 1.17

Industry 0.93

EPS

5.93

Sector -0.93

Industry -0.57

BVPS

34.22

Sector 3.88

Industry 5.17

Efficiency

Gross Margin

81.32%

Sector 44.07%

Industry 30.88%

Operating Margin

23.66%

Sector -25.88%

Industry -7.64%

Net Profit Margins

24.84%

Sector -30.34%

Industry -16.97%

Profitability

ROE

17.32%

Sector -34.57%

Industry -29.67%

ROA

15.72%

Sector -28.64%

Industry -15.42%

ROIC

22.11%

Sector -441.27%

Industry -111.79%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Debt

Equity/Assets

0.91

Sector 0.43

Industry 0.26

Liabilities/Assets

0.91

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

1.38%

Sector -

Industry -

5Y Earnings CAGR

14.93%

Sector -

Industry -

FAIR VALUE OF Abiomed ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$67.57

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ABMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
ISRG	39.67	6.81	17.15%	0.00%	$124.53 B	28.45%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.50 B	13.20%
BSX	18.45	2.54	13.78%	0.00%	$65.78 B	17.29%
RMD	19.01	4.45	23.41%	1.20%	$28.89 B	27.44%
TMDX	14.70	5.12	34.80%	0.00%	$2.53 B	27.04%
IDXX	41.21	29.00	70.38%	0.00%	$45.13 B	24.63%
SYK	36.85	5.35	14.52%	1.07%	$122.99 B	13.21%
PHG	22.75	1.95	8.56%	3.75%	$25.71 B	5.50%
COHR	114.66	4.88	4.26%	0.00%	$53.76 B	7.10%
INMD	11.26	1.48	13.18%	0.00%	$981.23 M	23.27%
DXCM	31.60	9.94	31.47%	0.00%	$29.40 B	19.31%
EW	45.55	4.82	10.58%	0.00%	$49.78 B	17.34%
BDX	39.08	1.84	4.72%	2.37%	$44.47 B	5.33%
IMRA	67.48	1.18	1.74%	114.25%	$105.94 M	0.00%
BDXB	8.75	0.54	6.12%	0.00%	$13.76 B	8.36%
ALGN	27.86	2.89	10.36%	0.00%	$11.97 B	10.50%
SNN	12.69	2.49	19.61%	2.52%	$13.16 B	8.66%
ZBH	23.50	1.41	6.00%	1.05%	$17.89 B	9.05%
IRMD	53.18	12.75	23.97%	1.28%	$1.26 B	27.36%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ABMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Abiomed

Abiomed Inc.

Average Investor10 user rating

4.0 (7 people)

United States

39 years

Founded: 1987

1987

Time since IPO - 39 years

1.536

Employees

Abiomed Inc. (United States) is listed on the Nasdaq and has a market capitalization of $17.15 billion, with shareholders equity totaling $1.54 billion.

The company employs approximately 1.536 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Abiomed Inc. reported $1.07 billion in revenue, generating net income of $266.76 million.

Key financial metrics include a P/E ratio of 64.27, a price-to-book (P/B) ratio of 11.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ABMD.

Market cap

$17.15 billion

Net worth

$1.54 billion

$1,539,790,000.00

Assets

$1.70 billion

$1,696,540,000.00

Total Shares Outstanding

45.00 million

45,000,000

Average Daily Trading Volume

$2.03 million

$2,027,669.70

Sector

Health

Industry

Medical Supplies and Equipment

ABMD

ABMD revenue and profits

Financial Results ABMD

DRAG THE FRAME TO SEE MORE DATA

ABMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$109.45 85,17% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$287.16 --0,45% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$67.22 145,04% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$407.13 85,54% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.80 --5,01% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,163.75 51,17% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$371.79 2,66% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$154.86 38,31% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56